Altogether, it is reasonable to conclude that CCL11 is a strong biomarker of persistent cognitive sequelae following mild COVID-19 and could be a key target for VCD treatment
Disruption of Wnt/-Catenin Signaling Exerts Antileukemia Activity and Sensitizes with Tyrosine Kinase Inhibitors in FLT3 Mutated AML In Vivo
A derivative of L-carnitine, ALCAR easily crosses the blood brain barrier where it increases brain carnitine levels and helps increase acetylcholine, an important neurotransmitter vital to learning, memory, and general cognition (severe depletion of acetylcholine is associated with Alzheimers disease)
Monitoring combines objective tests and patient reports
Norris AW, Ode KL, Merjaneh L, Sanda S, Yi Y, Sun X, et al
2019;7(1):e13958